Answers are grounded in this paper and cite their sources.
and predicts for therapeutic response to Met-selective RLT. This phenomenon can be exploited for other Met-overexpressing tumor types specifically, and to any differentially overexpressed surface molecule more broadly.
No takes yet. Share an insight, caveat, or question.
Escorcia et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: